| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 10 | |
| #2 | WIPO (World Intellectual Property Organization) | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Machines | |
| #3 | Biotechnology | |
| #4 | Measurement | |
| #5 | Surface technology and coating | |
| #6 | Chemical engineering |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Analysing materials | |
| #4 | Peptides | |
| #5 | Unspecified technologies | |
| #6 | Chemical or physical processes | |
| #7 | Layered products | |
| #8 | Certain plastics | |
| #9 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Simard J Marc | 12 |
| #2 | Chen Mingkui | 5 |
| #3 | Gerzanich Vladimir | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2011263478A1 | Sur1 inhibitors for therapy | |
| US2010092469A1 | Antagonists of a non-selective cation channel in neural cells | |
| WO2008089103A2 | Targeting ncca-atp channel for organ protection following ischemic episode | |
| US2006276411A1 | Methods for treating brain swelling with a compound that blocks a non-selective cation channel | |
| US2009130083A1 | Therapeutic methods that target the NCCA-ATP channel |